Abstract:The communication between glioblastoma stem cells (GSCs) and the surrounding microenvironment is a prominent feature accounting for the aggressive biology of glioblastoma multiforme (GBM). However, the mechanisms by which GSCs proactively drive interactions with microenvironment is not well understood. In this study, we interrogated metabolites that are preferentially secreted from GSCs and found that GSCs produce and secrete histamine to shape a pro-angiogenic tumor microenvironment. This histamine-producing ability is attributed to H3K4me3 modification-activated histidine decarboxylase (HDC) transcription via MYC. Notably, HDC is highly expressed in GBM, which is associated with poor survival of these patients. GSC-secreted histamine activates endothelial cells by triggering a histamine H1 receptor (H 1 R)-Ca 2+ -NF-κB axis, thereby promoting angiogenesis and GBM progression. Importantly, pharmacological blockage of H 1 R using antihistamines impedes the growth of GBM xenografts in mice. Our findings establish that GSC-specific metabolite secretion remodels the tumor microenvironment and highlight histamine targeting as a potential strategy for GBM therapy. Introduction Glioblastoma multiforme (GBM) is the most common and aggressive primary brain carcinoma in adults (Omuro, and DeAngelis, 2013 Omuro A. DeAngelis L.M. Glioblastoma and other malignant gliomas: a clinical review. JAMA. 2013; 310 : 1842-1850 Crossref PubMed Scopus (1426) Google Scholar ; Shergalis et al., 2018 Shergalis A. Bankhead 3rd, A. Luesakul U. Muangsin N. Neamati N. Current challenges and opportunities in treating glioblastoma. Pharmacol. Rev. 2018; 70 : 412-445 Crossref PubMed Scopus (339) Google Scholar ). Even with optimal treatment (comprising surgery, radiotherapy, and chemotherapy), patients with GBM still have poor prognoses (Aldape et al., 2019 Aldape K. Brindle K.M. Chesler L. Chopra R. Gajjar A. Gilbert M.R. Gottardo N. Gutmann D.H. Hargrave D. Holland E.C. et al. Challenges to curing primary brain tumours. Nat. Rev. Clin. Oncol. 2019; 16 : 509-520 Crossref PubMed Scopus (314) Google Scholar ). GBM contains an aggressive population of tumor cells known as glioblastoma stem cells (GSCs) due to their stem-like properties (Singh et al., 2004 Singh S.K. Hawkins C. Clarke I.D. Squire J.A. Bayani J. Hide T. Henkelman R.M. Cusimano M.D. Dirks P.B. Identification of human brain tumour initiating cells. Nature. 2004; 432 : 396-401 Crossref PubMed Scopus (5994) Google Scholar ; Vescovi et al., 2006 Vescovi A.L. Galli R. Reynolds B.A. Brain tumour stem cells. Nat. Rev. Cancer. 2006; 6 : 425-436 Crossref PubMed</l -Abstract Truncated-

PL-hMSC and CH-hMSC derived soluble factors inhibit proliferation but improve hGBM cell migration by activating TGF-β and inhibiting Wnt signaling

Hmga2 Sustains Self-Renewal and Invasiveness of Glioma-Initiating Cells

Inhibition of STAT3 signaling as critical molecular event in HUC-MSCs suppressed Glioblastoma Cells

Effects of transforming growth factor β-1 infected human bone marrow mesenchymal stem cells on high- and low-metastatic potential hepatocellular carcinoma

Mesenchymal Stem Cells As Therapeutic Agents and in Gene Delivery for the Treatment of Glioma

Bone Marrow Mesenchymal Stem Cells (BMSC) Exosome-Derived mR-512-5p Inhibits the Proliferation and Apoptosis of Glioblastoma Cells

Bisdemethoxycurcumin suppresses human brain glioblastoma multiforme GBM 8401 cell migration and invasion via affecting NF‐κB and MMP‐2 and MMP‐9 signaling pathway in vitro

Guggulsterone inhibits migration and invasion through proteasomal and lysosomal degradation in human glioblastoma cells

The embryonic stem cell microenvironment inhibits mouse glioma cell proliferation by regulating the PI3K/AKT pathway

Adipose-derived mesenchymal stem cells -conditioned medium effects on Glioma U87 cell line migration, apoptosis, and gene expression

Experimental study of TGFβ1 transfected hMSC intervene MHCC97-H

Integrated Analysis Reveals Prognostic Value and Mesenchymal Identity Suppression by Glycoprotein M6B in Glioma.

Growth Factors from Tumor Microenvironment Possibly Promote the Proliferation of Glioblastoma-Derived Stem-like Cells in Vitro

Glioblastoma Multiforme Stem Cell Cycle Arrest by Alkylaminophenol Through the Modulation of EGFR and CSC Signaling Pathways

VEGF Promotes Proliferation of Human Glioblastoma Multiforme Stem-Like Cells Through VEGF Receptor 2

Human neural stem cells repress glioma cell progression in a paracrine manner by downregulating the Wnt/β-catenin signalling pathway

Exosomes to control glioblastoma multiforme: Investigating the effects of mesenchymal stem cell-derived exosomes on C6 cells in vitro

Human Mesenchymal Stem Cells Inhibit Metastasis of a Hepatocellular Carcinoma Model Using the MHCC97‐H Cell Line

Glioblastoma stem cell-specific histamine secretion drives pro-angiogenic tumor microenvironment remodeling

Identification and validation of potential prognostic biomarkers in glioblastoma via the mesenchymal stem cell infiltration level

β2-microglobulin maintains glioblastoma stem cells and induces M2-like polarization of tumor-associated macrophages